News
Could UK clinical trial revamp unlock closer ties with Canad...
Two senior figures in Canada's life science sector have said they see scope for greater collaboration with the UK following clinical trial reforms.
R&D
Mosquitoes, malaria, and UK R&D viral disease vaccine invest...
The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
News
Amgen's Imdelltra scores again in small cell lung cancer
Amgen's Imdelltra and AstraZeneca's Imfinzi have improved survival compared to Imfinzi alone as first-line maintenance treatment for ES-SCLC.
News
BMS eyes role for new CAR-T in post-BCMA multiple myeloma
BMS' arlo-cel has shown activity in a trial that could underpin filings in multiple myeloma settings where the four main drug classes have failed.
News
FDA starts review of AZ's COPD blockbuster hope
The FDA has started a priority review of AstraZeneca's first-in-class IL-33 inhibitor tozorakimab for COPD, setting up a decision in Q1 of 2027.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
